Production (Stage)
MediWound Ltd.
MDWD
$20.33
-$0.53-2.54%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 9.40% | 6.08% | 30.67% | -54.05% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 9.40% | 6.08% | 30.67% | -54.05% | |
| Cost of Revenue | 6.88% | 26.95% | 46.55% | 33.50% | |
| Gross Profit | 25.59% | -60.69% | -26.51% | -91.19% | |
| SG&A Expenses | 43.27% | -2.79% | -7.03% | -5.71% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -91.96% | -- | -- | -- | |
| Total Operating Expenses | 26.45% | 8.74% | 6.55% | 5.92% | |
| Operating Income | -48.62% | -11.90% | 14.44% | -251.87% | |
| Income Before Tax | -139.68% | -779.63% | -163.15% | 78.04% | |
| Income Tax Expenses | -85.00% | -116.67% | 380.00% | 84.62% | |
| Earnings from Continuing Operations | -124.21% | -788.32% | -163.44% | 76.63% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -124.21% | -788.32% | -163.44% | 76.63% | |
| EBIT | -48.62% | -11.90% | 14.44% | -251.87% | |
| EBITDA | -50.40% | -11.78% | 17.11% | -235.83% | |
| EPS Basic | -91.64% | -782.91% | -139.29% | 83.95% | |
| Normalized Basic EPS | 67.23% | -774.29% | -- | -8.68% | |
| EPS Diluted | -91.64% | -782.91% | -139.29% | 83.95% | |
| Normalized Diluted EPS | 67.23% | -774.29% | -- | -8.68% | |
| Average Basic Shares Outstanding | 17.04% | 0.77% | 10.09% | 45.59% | |
| Average Diluted Shares Outstanding | 17.04% | 0.77% | 10.09% | 45.59% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |